Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases

World Journal of Surgery

Volumn 30, Issue 9, 2006, Pages 1653-1657

  Carcoforo, P ^a   Maestroni, U ^a   Querzoli, P ^a   Lanzara, S ^a   Maravegias, K ^a   Feggi, L ^b   Soliani, G ^a   Basaglia, E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CHI SQUARE DISTRIBUTION; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MICROMETASTASIS; MITOSIS INDEX; PATIENT CODING; PREDICTION; SENTINEL LYMPH NODE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; SENTINEL LYMPH NODE BIOPSY;

EID: 33748783347     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0083-0     Document Type: Conference Paper

References (19)

1. Kell MR, Winter DC, O'Sullivan GC, et al. Biological behaviour and clinical implications of micrometastases. Br J Surg 2000;87:1629-1639.
2. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg 2002;89:1505-1515.
3. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-541.
4. Zgajnar J, Besic N, Podkrajsek M, et al. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes. Eur J Cancer 2005;41:244-248.
5. Langer I, Marti WR, Guller U, et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005;241:152-158.
6. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-581.
7. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384.
8. Leidenius MH, Vironen JH, Riihela MS, et al. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 2005;31:13-18.
9. Menes TS, Tartter PI, Mizrachi H, et al. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg 2005;200:323-327.
10. Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 2004;91:1245-1252.
11. Trojani M, de Mascarel I, Coindre JM, et al. Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;56:838-839.
12. de Mascarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-527.
13. Gebauer G, Fehm T, Merkle E, et al. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients - prognostic relevance after 10 years. Anticancer Res 2003;23:4319-4324.
14. Sedmak DD, Meineke TA, Knechtges DS, et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-520.
15. Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30:807-816.
16. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005;23:1379-1389.
17. Cox C, DuPont EL, Furman B, et al. The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients. Am J Surg 2003;186:333-336.
18. Nos C, Harding-MacKean C, Freneaux P, et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003;90:1354-1360.
19. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145-149.